Clinical Trials Directory

Trials / Unknown

UnknownNCT04995965

Infections With Enterobacteria Producing Carbapenemases at the University Hospitals of Strasbourg

Infections With Enterobacteria Producing Carbapenemases at the University Hospitals of Strasbourg - Descriptive Epidemiology and Risk Factors for Infection in the Event of Colonization

Status
Unknown
Phase
Study type
Observational
Enrollment
274 (estimated)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Infections with enterobacteria producing carbapenemases at the University Hospitals of Strasbourg - descriptive epidemiology and risk factors for infection in the event of colonization There is a worrying situation of an increase in the number of patients colonized with carbapenemase-producing Enterobacteriaceae (CPE) at HUS. 7 to 15% of patients colonized with EPC would develop an infection with EPC. The cohorts published mainly concern patients hospitalized in intensive care. The associated mortality reported in the literature is high (\> 25%) and greater than that associated with infection with the same bacterium sensitive to carbapenems.

Conditions

Timeline

Start date
2021-08-06
Primary completion
2022-01-06
Completion
2022-01-06
First posted
2021-08-09
Last updated
2021-08-09

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04995965. Inclusion in this directory is not an endorsement.

Infections With Enterobacteria Producing Carbapenemases at the University Hospitals of Strasbourg (NCT04995965) · Clinical Trials Directory